369 related articles for article (PubMed ID: 36834870)
1. Induced Pluripotent Stem Cell-Derived Organoids: Their Implication in COVID-19 Modeling.
Csöbönyeiová M; Klein M; Kuniaková M; Varga I; Danišovič Ľ
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834870
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 research using human pluripotent stem cells and organoids.
Deguchi S; Serrano-Aroca Á; Tambuwala MM; Uhal BD; Brufsky AM; Takayama K
Stem Cells Transl Med; 2021 Nov; 10(11):1491-1499. PubMed ID: 34302450
[TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019.
Chakrabarty K; Shetty R; Argulwar S; Das D; Ghosh A
Cytotherapy; 2022 Mar; 24(3):235-248. PubMed ID: 34656419
[TBL] [Abstract][Full Text] [Related]
4. A potential ex vivo infection model of human induced pluripotent stem cell-3D organoids beyond coronavirus disease 2019.
Zhou H; Liu LP; Fang M; Li YM; Zheng YW
Histol Histopathol; 2020 Oct; 35(10):1077-1082. PubMed ID: 32339250
[TBL] [Abstract][Full Text] [Related]
5. Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response.
Mithal A; Hume AJ; Lindstrom-Vautrin J; Villacorta-Martin C; Olejnik J; Bullitt E; Hinds A; Mühlberger E; Mostoslavsky G
Stem Cell Reports; 2021 Apr; 16(4):940-953. PubMed ID: 33852884
[TBL] [Abstract][Full Text] [Related]
6. Establishment of Human Pluripotent Stem Cell-Derived Skin Organoids Enabled Pathophysiological Model of SARS-CoV-2 Infection.
Ma J; Liu J; Gao D; Li X; Zhang Q; Lv L; Wang Y; Li J; Zhu Y; Wu Z; Hu H; Li Y; Ma L; Liu Q; Hu Z; Zhang S; Zhou Y; Wang M; Leng L
Adv Sci (Weinh); 2022 Mar; 9(7):e2104192. PubMed ID: 34971128
[TBL] [Abstract][Full Text] [Related]
7. Induced Pluripotent Stem Cell Derived Human Lung Organoids to Map and Treat the SARS-CoV2 Infections In Vitro.
Bose B; Kapoor S; Nihad M
Adv Exp Med Biol; 2021; 1312():1-17. PubMed ID: 33385178
[TBL] [Abstract][Full Text] [Related]
8. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.
Qian L; Tcw J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530458
[TBL] [Abstract][Full Text] [Related]
9. iPSC-derived three-dimensional brain organoid models and neurotropic viral infections.
Swingler M; Donadoni M; Bellizzi A; Cakir S; Sariyer IK
J Neurovirol; 2023 Apr; 29(2):121-134. PubMed ID: 37097597
[TBL] [Abstract][Full Text] [Related]
10. iPSCs-Derived Platform: A Feasible Tool for Probing the Neurotropism of SARS-CoV-2.
Mao XY; Jin WL
ACS Chem Neurosci; 2020 Sep; 11(17):2489-2491. PubMed ID: 32840109
[TBL] [Abstract][Full Text] [Related]
11. Unravelling Pathophysiology of Neurological and Psychiatric Complications of COVID-19 Using Brain Organoids.
Ng JH; Sun A; Je HS; Tan EK
Neuroscientist; 2023 Feb; 29(1):30-40. PubMed ID: 34036855
[TBL] [Abstract][Full Text] [Related]
12. Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery.
Giani AM; Chen S
Stem Cell Res; 2021 May; 53():102207. PubMed ID: 33677394
[TBL] [Abstract][Full Text] [Related]
13. Generation of Angiotensin-Converting Enzyme 2/Transmembrane Protease Serine 2-Double-Positive Human Induced Pluripotent Stem Cell-Derived Spheroids for Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Drug Evaluation.
Higashi-Kuwata N; Yabe SG; Fukuda S; Nishida J; Tamura-Nakano M; Hattori SI; Okochi H; Mitsuya H
Microbiol Spectr; 2022 Dec; 10(6):e0349022. PubMed ID: 36314907
[TBL] [Abstract][Full Text] [Related]
14. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.
Pei R; Feng J; Zhang Y; Sun H; Li L; Yang X; He J; Xiao S; Xiong J; Lin Y; Wen K; Zhou H; Chen J; Rong Z; Chen X
Protein Cell; 2021 Sep; 12(9):717-733. PubMed ID: 33314005
[TBL] [Abstract][Full Text] [Related]
15. iPSC-derived mesenchymal cells that support alveolar organoid development.
Tamai K; Sakai K; Yamaki H; Moriguchi K; Igura K; Maehana S; Suezawa T; Takehara K; Hagiwara M; Hirai T; Gotoh S
Cell Rep Methods; 2022 Oct; 2(10):100314. PubMed ID: 36313800
[TBL] [Abstract][Full Text] [Related]
16. Using human iPSC-derived kidney organoids to decipher SARS-CoV-2 pathology on single cell level.
Reimer KC; Jansen J; Overheul GJ; Miesen P; van Rij RP; Triana SH; Smeets B; Schneider RK; Kramann R
STAR Protoc; 2022 Sep; 3(3):101612. PubMed ID: 35983169
[TBL] [Abstract][Full Text] [Related]
17. Modeling of Respiratory Diseases Evolving with Fibrosis from Organoids Derived from Human Pluripotent Stem Cells.
Chamorro-Herrero I; Zambrano A
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901843
[TBL] [Abstract][Full Text] [Related]
18. Advanced In Vitro Lung Models for Drug and Toxicity Screening: The Promising Role of Induced Pluripotent Stem Cells.
Moreira A; Müller M; Costa PF; Kohl Y
Adv Biol (Weinh); 2022 Feb; 6(2):e2101139. PubMed ID: 34962104
[TBL] [Abstract][Full Text] [Related]
19. Generation of Complete Multi-Cell Type Lung Organoids From Human Embryonic and Patient-Specific Induced Pluripotent Stem Cells for Infectious Disease Modeling and Therapeutics Validation.
Leibel SL; McVicar RN; Winquist AM; Niles WD; Snyder EY
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e118. PubMed ID: 32640120
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids.
Menuchin-Lasowski Y; Schreiber A; Lecanda A; Mecate-Zambrano A; Brunotte L; Psathaki OE; Ludwig S; Rauen T; Schöler HR
Stem Cell Reports; 2022 Apr; 17(4):789-803. PubMed ID: 35334213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
